Crinetics Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Crinetics Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 80.8M shares, a 21.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 80.8M +14.1M +21.2% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 79.3M +24.6M +45.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 78.5M +24.5M +45.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 68.2M +14.3M +26.5% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 66.7M +12.9M +24% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 54.7M +962K +1.79% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 54M +6.19M +12.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 53.9M +6.28M +13.2% Dec 31, 2022 10-K 2024-02-28
Q3 2022 53.8M +15.2M +39.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 53.7M +16M +42.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 47.8M +14.8M +44.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 47.6M +14.6M +44.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 38.6M +5.68M +17.3% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 37.7M +4.78M +14.5% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 33M +8.42M +34.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 33M +8.72M +35.9% Dec 31, 2020 10-K 2022-03-30
Q3 2020 32.9M +8.68M +35.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 32.9M +8.66M +35.7% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 24.6M +405K +1.67% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 24.3M +24.3M Dec 31, 2019 10-K 2021-03-30
Q3 2019 24.3M +90K +0.37% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 24.2M +21.8M +876% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 24.2M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 24.2K* -2.05M Dec 31, 2018 10-K 2020-03-09
Q3 2018 24.2M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 2.48M Jun 30, 2018 10-Q 2018-08-30
Q4 2017 2.08M Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.